News › Industry News, State Laws

A telehealth website sold patients obesity drugs at affordable rates. Now they’re paying the price

February 11, 2025

Patients in Florida purchased three-month supplies of compounded tirzepatide from a telehealth provider. The compounding pharmacy that filled their prescriptions was found not to have a sterile compounding license, making thousands of dollars in medication potentially unsafe and at risk of contamination.

The Florida Department of Public Health filed a complaint against the compounding pharmacy, claiming that it was compounding without a sterile compounding license, improperly storing medicines that needed to be refrigerated and failing to document drugs it dispensed. Lack of this license is a violation of state license law.

Patients should be informed of which pharmacy is filling their prescriptions and know that patient counseling is available from licensed pharmacies in Florida.

Read more at NPR >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • ByrdAdatto Attorneys Recognized in the 2027 Edition of Best Lawyers
    • RHA Redensity Eye Receives FDA Approval for Undereye Hollowing
    • South Carolina Medical Board Warns Against Use of Research-Grade Peptides
    • Lilly Sues Six Companies Over Alleged Sales of Experimental Weight-Loss Drug Retatrutide
    • DaySpark Becomes Silver Vendor Affiliate with the American Med Spa Association
Advertisement